Peter Thompson, Terremoto Biosciences CEO
OrbiMed and Third Rock’s Terremoto Biosciences raises $175M for small molecule R&D
Terremoto Biosciences has reeled in $175 million to create small molecules based on work from Principia Biopharma co-founder Jack Taunton and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
